Search

everythinglearnresearchcommunity

for

Search:↓

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Two mouse mutations cause similar hair loss despite different skin changes.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

A rare skin condition was misdiagnosed as a harmless mole on a woman's eyelid.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Targeting Vδ1+T-cells may help treat alopecia areata.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

A bull got very sick and had to be put down after eating hairy vetch for months.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Erianin may effectively treat alopecia areata by targeting the immune system.